Andreas Strüngmann

Andreas Strüngmann (1950-) founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. In February 2005, he and his brother sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion.

[edit]

See also

[edit]

External links

 This business-related biographical article is a stub. You can help Wikipedia by expanding it.
Retrieved from "http://www.dictionpedia.com/en/Andreas_Str%C3%BCngmann"